FOXO TECHNOLOGIES INC. — fact timeline

FOXO TECHNOLOGIES INC. entered into Strategic Technology License Agreement with Jon R. Sabes and LongevityFP Technologies, LLC valued at 3% of net revenues derived from commercialization of the Licensed IP, subject to an aggregate cap of (effective 2026-05-27).

“On May 27, 2026, FOXO Technologies Inc. (the “ Company ”), together with its wholly-owned subsidiary, FOXO Labs, Inc. (“ FLI ”), entered into a Strategic Technology License Agreement (the “ Agreement ”) with Jon R. Sabes, the Company’s founder, and LongevityFP Technologies, LLC”

FOXO TECHNOLOGIES INC. issued 400 shares of preferred stock to J.H. Darbie & Co., Inc..

“In connection with the Settlement Agreement, the Company issued 400 shares of Series D Preferred Stock to J.H. Darbie, convertible into shares of Class A Common Stock in accordance with the Series D Preferred Stock Certificate of Designation.”

FOXO TECHNOLOGIES INC. shareholders approved Amendment to Certificate of Incorporation to effect a reverse stock split at a ratio ranging from 1:1,000 to 1:10,000.

“the Majority Stockholder approved: 1. An amendment”

FOXO TECHNOLOGIES INC. entered into Exchange Agreement with each of (i) an institutional investor ("Investor 1") and (ii) a second institutional investor ("Investor 2") (effective 2026-05-12).

“On May 12, 2026, FOXO Technologies Inc., a Delaware corporation (the " Company "), entered into two Exchange Agreements (each, an " Exchange Agreement " and collectively, the " Exchange Agreements "), each dated as of May 12, 2026, by and between the Company and each of (i) an institutional investor (" Investor 1 ") and (ii) a second institutional investor (" Investor 2 " and, together with Investor 1, the " Holders "), each a holder of the Company’s Series A Cumulative Convertible Redeemable Preferred Stock (the " Series A Preferred Stock ").”

FOXO TECHNOLOGIES INC.: Increased authorized shares of capital stock from previous amount to 25,020,000,000 shares, amending Article IV, Subsection 1 of the Certificate of Incorporation (effective 2026-05-03).

“on April 15, 2026, the Company signed and submitted for filing a Certificate of Amendment to its Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase its authorized shares of capital stock, amending Article IV, Subsection 1 of the Certificate of Incorporation, as amended, to provide that the total number of shares of capital stock that the Company shall have authority to issue is 25,020,000,000 shares”

FOXO TECHNOLOGIES INC. issued 8,000 shares of the Company’s Series E Cumulative Redeemable Secured Preferred Stock of preferred stock to Rennova Health, Inc. for full satisfaction and extinguishment of $200,000 in aggregate previously advanced amounts.

“”) effective December 31, 2025 with Rennova Health, Inc., a Delaware corporation (“ Rennova ”). Pursuant to the Exchange Agreement, in full satisfaction and extinguishment of $200,000 in aggregate previously advanced amounts (the “ Prior Advances ”) made by Rennova to the Company during the period from December 4, 2025 to December 10, 2025, the Company agreed”

FOXO TECHNOLOGIES INC. entered into Series E Preferred Stock Exchange Agreement with Rennova Health, Inc. valued at $200,000 (effective 2025-12-31).

“On February 6, 2026, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), entered into a Series E Preferred Stock Exchange Agreement (the “ Exchange Agreement ”) effective December 31, 2025 with Rennova Health, Inc., a Delaware corporation (“ Rennova ”). Pursuant to the Exchange Agreement, in full satisfaction and extinguishment of $200,000 in aggregate previously advanced amounts (the “ Prior Advances ”) made by Rennova to the Company”

FOXO TECHNOLOGIES INC.: Increased authorized shares of Common Stock from 2,500,000,000 to 10,000,000,000 (effective 2026-01-18).

“the Company filed a Certificate of Amendment to its Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase its authorized shares of Common Stock, $0.0001 par value per share, from 2,500,000,000 shares to 10,000,000,000 shares, which filing became effective on January 18, 2026”

FOXO TECHNOLOGIES INC.: Filed Amended Designations for Series B and Series C Preferred Stock, revising conversion price and removing mandatory conversion provision, and exempting dividends on Series E Preferred Stock from certain restrictions (effective 2025-12-16).

“On December 16, 2025, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), filed amendments to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of Amended and Restated Certificates of Designation (the “ Amended Designations ”) of the Company’s previously designated “Series B Cumulative Convertible Redeemable Preferred Stock” (the “ Series B Preferred Stock ”) and the Company’s previously designated “Series C Cumulative Convertible Redeemable Preferred Stock” (the “ Series C Preferred Stock ”).”

FOXO TECHNOLOGIES INC.: 修改了Series D优先股的转换价格计算方式，并澄清Series E优先股股息为半年支付而非季度支付。 (effective 2025-10-29).

“The Amended Designation for the Series D Preferred Stock: revises the conversion price to equal the higher of $0.0001 (such dollar amount not being subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Class A Common Stock) or 90% of the average VWAP of the five trading days immediately prior to the date the Conversion Notice is tendered by the holder. The Amended Designation for the Series E Preferred Stock clarified that dividends are paid semi-annually, not quarterly.”

FOXO TECHNOLOGIES INC.: Amended certificate of incorporation to increase authorized common stock from 500,000,000 to 2,500,000,000 shares (effective 2025-10-22).

“the Company filed a Certificate of Amendment to its Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase its authorized shares of Common Stock, $0.0001 par value per share, from 500,000,000 shares to 2,500,000,000 shares, which filing became effective on October 22, 2025”

FOXO TECHNOLOGIES INC.: Amended and Restated Certificate of Designation for Series A Preferred Stock increasing authorized shares to 50,000, revising voting rights and conversion price, and allowing cash dividends (effective 2025-09-22).

“On September 22, 2025, the Company filed an amendment to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of an Amended and Restated Certificate of Designation (the “ Amended Designation ”) of the Company’s previously designated "Series A Cumulative Convertible Redeemable Preferred Stock" (the “ Series A Preferred Stock ”). The Amended Designation: increases the authorized shares of Series A Preferred stock to 50,000, revises the voting rights to entitle the holder of Series A Preferred Stock to cast the number of votes determined by dividing the Stated Value of such share of Series A Preferred Stock by $0.0001 (such dollar amount not being subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Class A Common Stock), revises the conversion price to equal the higher of $0.0001 (such dollar amount not being subject to adjustment for reverse and forward stock splits”

FOXO TECHNOLOGIES INC. issued Not provided in excerpt of warrant to Sellers named in Stock Purchase Agreement for Not provided in excerpt.

“The shares of Series E Preferred Stock and the Warrants were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and by Rule 506(b) of Regulation D promulgated thereunder as a transaction by an issuer not involving any public offering and based, in part, on the representations of the investor.”

FOXO TECHNOLOGIES INC. issued Not provided in excerpt of preferred stock to Sellers named in Stock Purchase Agreement for Not provided in excerpt.

“The shares of Series E Preferred Stock and the Warrants were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and by Rule 506(b) of Regulation D promulgated thereunder as a transaction by an issuer not involving any public offering and based, in part, on the representations of the investor.”

FOXO TECHNOLOGIES INC. received a nyse_american delisting notice notice regarding minimum bid price (rules 1003(f)(v)).

“August 12, 2025, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), received a letter from NYSE confirming that NYSE Regulation has determined to commence proceedings to delist the Class A Common Stock of the Company from NYSE American, pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Class A Common Stock. The share price went below the NYSE minimum price of $0.10 on August 12, 2025 and was immediately suspended from trading by NYSE. The Company submitted an application to have its common stock traded on the OTC and has on Aug”

FOXO TECHNOLOGIES INC. reported that prior financial statements should not be relied upon.

“On August 14, 2025, the board of directors (the “Board”) of the Company concluded that the previously issued unaudited condensed consolidated financial statements contained in the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025 (the “Original 10-Q”) should no longer be relied upon because of an error in those financial statements”

FOXO TECHNOLOGIES INC.: The Company amended its Second Amended and Restated Certificate of Incorporation to implement a 1-for-1.99 reverse stock split of its Class A Common Stock, effective July 27, 2025 (effective 2025-07-27).

“On July 27, 2025, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), amended its Second Amended and Restated Certificate of Incorporation, as amended (the “ Charter Amendment ”), to implement a 1-for-1.99 reverse stock split, such that every 1.99 shares of Class A Common Stock (the “ Common Stock ”) was combined into one issued and outstanding share of Common Stock, with no change in the $0.0001 par value per share (the “ Reverse Stock Split ”).”

FOXO TECHNOLOGIES INC.: Filed a Certificate of Designation to authorize up to 4,000,000 shares of Series E Cumulative Redeemable Secured Preferred Stock and establish its rights, preferences and limitations (effective 2025-06-25).

“On June 25, 2025, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), filed an amendment to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of a Certificate of Designation (the “ Designation ”) that authorized for issuance of up to 4,000,000 shares of a new series of Preferred Stock, par value $0.0001 per share, of the Company designated “Series E Cumulative Redeemable Secured Preferred Stock” (the “ Series E Preferred Stock ”) and established the rights, preferences and limitations thereof.”

Seamus Lagan was appointed as Interim Chief Financial Officer at FOXO TECHNOLOGIES INC..

“On June 13, 2025, the Board of Directors of the Company (with Mr. Lagan abstaining) appointed Seamus Lagan to serve as the Company’s Interim Chief Financial Officer.”

Martin Ward departed as Interim Chief Financial Officer at FOXO TECHNOLOGIES INC..

“On June 9, 2025, Martin Ward, the Company’s Interim Chief Financial Officer passed away unexpectedly.”

FOXO TECHNOLOGIES INC.: Implemented a 1-for-10 reverse stock split of Class A Common Stock (effective 2025-04-28).

“On April 22, 2025, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), amended its Second Amended and Restated Certificate of Incorporation, as amended (the “ Charter Amendment ”), to implement a 1-for-10 reverse stock split”

FOXO TECHNOLOGIES INC.: Removed automatic conversion right at two-year anniversary for Series D Preferred Stock (effective 2025-03-31).

“On March 31, 2025, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), filed an amendment to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of an Amendment to the Certificate of Designation (the “ Amended Designation ”) of the Company’s previously designated “Series D Cumulative Convertible Redeemable Preferred Stock” (the “ Series D Preferred Stock ”). The Amended Designation removes Section 6(e), which was the right to an automatic conversion at the two-year anniversary from issuance, which, if retained, could mean the value issued being treated as a liability on the Company’s balance sheet.”

FOXO TECHNOLOGIES INC.: Added beneficial ownership limitation of 4.99% (or up to 9.99% upon holder election) to Amended and Restated Certificate of Designation for Series A Preferred Stock (effective 2024-12-27).

“On December 27, 2024, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), filed an amendment to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of an Amended and Restated Certificate of Designation (the “ Amended Designation ”) of the Company’s previously designated “Series A Cumulative Convertible Redeemable Preferred Stock” (the “ Series A Preferred Stock ”).”

FOXO TECHNOLOGIES INC.: On December 6, 2024, FOXO Technologies Inc. filed a Certificate of Designation creating a new Series D Cumulative Convertible Redeemable Preferred Stock, authorizing up to 10,000 shares with specific voting, dividend, liquidation, and conversion rights (effective 2024-12-06).

“On December 6, 2024, the Company filed amendments to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of a Certificate of Designation (the “ Designation ”) that authorized for issuance of up to 10,000 shares of a new series of Preferred Stock, par value $0.0001 per share, of the Company designated “Series D Cumulative Convertible Redeemable Preferred Stock” (the “ Series D Preferred Stock ”) and established the rights, preferences and limitations thereof.”

FOXO TECHNOLOGIES INC.: Authorized issuance of Series B and Series C Cumulative Convertible Redeemable Preferred Stock and established their rights, preferences and limitations (effective 2024-11-27).

“On November 27, 2024, FOXO Technologies Inc. a Delaware corporation (the “ Company ” or the “ Corporation ”) filed amendments to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of two Certificates of Designation (the “ Designations ”) that authorized for issuance of up to 7,500 shares of a new series of Preferred Stock, par value $0.0001 per share, of the Company designated “Series B Cumulative Convertible Redeemable Preferred Stock” (the “ Series B Preferred Stock ”) and that authorized for issuance of up to 5,000 shares of a new series of Preferred Stock, par value $0.0001 per share, of the Company designated “Series C Cumulative Convertible Redeemable Preferred Stock” (the “ Series C Preferred Stock ”) and established the rights, preferences and limitations thereof.”

FOXO TECHNOLOGIES INC.: Reduced shareholder quorum requirement from a majority to one-third (effective 2024-10-21).

“the Amended and Restated Bylaws of the Company (the “ Amended Bylaws ”). The Amended Bylaws, which revise the quorum requirements for a meeting of the Company’s shareholders from a majority to one-third, amend Section 2.4”

FOXO TECHNOLOGIES INC.: Filed a Certificate of Designation establishing Series A Cumulative Convertible Redeemable Preferred Stock, authorizing up to 35,000 shares with specified rights, preferences, and limitations (effective 2024-10-18).

“On October 18, 2024, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), filed an amendment to the Company’s Certificate of Incorporation (the “ Certificate of Incorporation ”), in the form of a Certificate of Designation (the “ Designation ”) that authorized for issuance of up to 35,000 shares of a new series of Preferred Stock, par value $0.0001 per share, of the Company designated “Series A Cumulative Convertible Redeemable Preferred Stock” (the “ Series A Preferred Stock ”) and established the rights, preferences and limitations thereof.”

Trevor Langley was appointed as Director at FOXO TECHNOLOGIES INC..

“the board of directors (the “ Board ”) of the Company appointed Seamus Lagan and Trevor Langley to the Board to serve as directors of the Company, effective September 10, 2024.”

Seamus Lagan was appointed as Director at FOXO TECHNOLOGIES INC..

“the board of directors (the “ Board ”) of the Company appointed Seamus Lagan and Trevor Langley to the Board to serve as directors of the Company, effective September 10, 2024.”

FOXO TECHNOLOGIES INC. completed an acquisition involving Rennova Health, Inc. for $500,000 (closed 2024-07-17).

“exchanged with the Company 100 shares of Common Stock of Myrtle (which represents 98.4% of the issued and outstanding shares of Myrtle Common Stock) for total consideration of $500,000 (the “ Myrtle Purchase Price ”), which payment was made by the issuance of a number of shares of Class A Common Stock of the Company determined by dividing $500,000 by the volume”

FOXO TECHNOLOGIES INC. completed an acquisition involving Rennova Health, Inc. for $500,000 (closed 2024-07-17).

“exchange with the Company 100 shares of Common Stock of Myrtle (which represents 98.4% of the issued and outstanding shares of Myrtle Common Stock) for total consideration of $500,000 (the “ Myrtle Purchase Price ”), which payment will be made by the issuance of a number of shares of Class A Common Stock of the Company determined by dividing $500,000 by the”

FOXO TECHNOLOGIES INC. received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

“tification ”) due to the failure to timely file the Company’s Annual Report on Form 10-Q for the year ended December 31, 2023 (the “ Delinquent Report ”) by the filing due date of April 16, 2024 (the “ Filing Delinquency ”). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide. Within five days of the date of the Filing Delinquency Notification, the Company was required to (a) contact the NYSE to discuss the status of the Delinquent Report and (b) issue a press release disclosing the occurrence of the Filing Delinquency, the”

FOXO TECHNOLOGIES INC. incurred loan of up to $750,000 with ClearThink Capital Partners, LLC at 12% per annum (22% after the occurrence of an Event of Default) maturing January 30, 2025.

“to issue to ClearThink a promissory note on January 30, 2024 in the principal amount of up to $750,000 (the “ Note ”). The Note matures on January 30, 2025 and has an interest rate of 12% per annum (22% after the occurrence of an Event of Default”

FOXO TECHNOLOGIES INC. entered into Strata Purchase Agreement with ClearThink Capital Partners, LLC valued at up to an aggregate of $5,000,000 (effective 2024-02-01).

“On February 1, 2024, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), entered into a Strata Purchase Agreement (the “ Strata Purchase Agreement ”) with ClearThink Capital Partners, LLC (“ ClearThink ”). Pursuant to the Strata Purchase Agreement, after the satisfaction of certain commencement conditions, including, without limitation, the effectiveness of the Registration Statement (as defined below), ClearThink has agreed to purchase from the Company, from time to time upon delivery by the Company to ClearThink of request notices (each a “ Request Notice ”), and subject to the other terms and conditions set forth in the Strata Purchase Agreement, up to an aggregate of $5,000,000 of the Company’s Class A common stock, par value $0.0001 per share (the “ Common Stock ”).”

FOXO TECHNOLOGIES INC. received a nyse_american deficiency notice notice regarding audit committee.

“January 19, 2024, FOXO Technologies Inc., a Delaware corporation(the “ Company ”), received an official notice of noncompliance (the “ NYSE American Notice ”) from NYSE Regulation (“ NYSE ”) stating that the Company is noncompliant with Sections 803B(2)(c) and 803B(2)(a)(iii) of the Company Guide since its audit committee is not comprised of two independent members and does not have at least one member of the audit committee who is financially sophisticated. According to Section 803(B)(6)(b) of the Company Guide, the Company will have until the earlier of its next annual meeting or one year fr”

Francis Colt deWolf III was appointed as Director at FOXO TECHNOLOGIES INC..

“appointed Francis Colt deWolf III to the Board to serve as a director of the Company, effective immediately.”

FOXO TECHNOLOGIES INC. entered into Master Software and Services Agreement with KR8 AI Inc. valued at $2,500,000 (effective 2024-01-12).

“Effective January 12, 2024, Foxo Technologies Inc., a Delaware corporation (the “ Company ” or the “ Licensee ”), entered into the Master Software and Services Agreement (this “ Agreement ”) with KR8 AI Inc., a Nevada corporation (the “ Licensor ”).”

FOXO TECHNOLOGIES INC. received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

“inquency Notification ”) due to the failure to timely file the Company’s Form 10-Q for the period ended September 30, 2023 (the “ Delinquent Report ”) by the filing due date of November 20, 2023 (the “ Filing Delinquency ”). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide. Within five days of the date of the Filing Delinquency Notification, the Company was required to (a) contact the NYSE to discuss the status of the Delinquent Report and (b) issue a press release disclosing the occurrence of the Filing Delinquency, the”

Andrew Poole resigned as director at FOXO TECHNOLOGIES INC..

“Effective November 21, 2023, the Company accepted the resignation of Andrew Poole from the Board of Directors of the Company.”

FOXO TECHNOLOGIES INC. entered into Settlement Agreement with Smithline Family Trust II, as Assignee of Puritan Partners LLC valued at $2,300,000 in cash (effective 2023-11-07).

“On November 7, 2023, Smithline, on the one hand, and the Company and its subsidiaries, on the other hand, entered into a settlement agreement (the “Settlement Agreement”)”

FOXO TECHNOLOGIES INC.: Amended Second Amended and Restated Certificate of Incorporation to implement a 1-for-10 reverse stock split (effective 2023-11-06).

“On October 31, 2023, the Company amended its Second Amended and Restated Certificate of Incorporation, as amended (the “Charter Amendment”), to implement a 1-for-10 reverse stock split, such that every 10 shares of Common Stock will be combined into one issued and outstanding share of Common Stock, with no change in the $0.0001 par value per share (the “Reverse Stock Split”). The Reverse Stock Split will be effective at 4:01 p.m., Eastern Time, on November 6, 2023.”

FOXO TECHNOLOGIES INC. reported a default on senior notes of aggregate principal amount of $3,457,500 at 15% per annum (compounded quarterly on each December 20, March 20, June 20 and S maturing April 1, 2024.

“As previously disclosed, on September 20, 2022, the Company issued to certain investors 15% Senior Promissory Notes (the “PIK Notes”) in an aggregate principal amount of $3,457,500, each with a maturity date of April 1, 2024 (the “Maturity Date”). Pursuant to the terms of the PIK Notes, commencing on November 1, 2023, and on each one month anniversary”

FOXO TECHNOLOGIES INC. entered into Letter Agreement with KR8 AI Inc. valued at $2,500,000 (effective 2023-10-29).

“On October 29, 2023, FOXO Technologies Inc. (the “Company”) entered into a letter agreement (the “Letter Agreement”) with KR8 AI Inc. (“KR8”), pursuant to which KR8 granted the Company a provisional exclusive license (the “License”) to use KR8’s KR8 AI Eco System and iOS/Android app to develop one or more consumer health, wellness and longevity apps.”

FOXO TECHNOLOGIES INC. received a nyse_american deficiency notice notice regarding other.

“October 31, 2023, the Company received notice from NYSE American that NYSE American had halted trading in the Common Stock until the effectiveness of the Reverse Stock Split (as defined in”

FOXO TECHNOLOGIES INC. entered into Registration Rights Agreement with ClearThink Capital Partners, LLC (effective 2023-10-13).

“In connection with the Strata Purchase Agreement, the Company entered into a Registration Rights Agreement with ClearThink under which the Company agreed to file, within 60 days of executing definitive documents, a registration statement (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) covering the shares of Common Stock issuable under the Strata Purchase Agreement (the “Registration Rights Agreement”).”

FOXO TECHNOLOGIES INC. entered into Securities Purchase Agreement with ClearThink Capital Partners, LLC valued at $200,000 (effective 2023-10-13).

“Concurrently with the execution of the Strata Purchase Agreement, the Company and ClearThink also entered into a Securities Purchase Agreement (the “SPA”) under which ClearThink has agreed to purchase from the Company an aggregate of 2,000,000 restricted shares of Common Stock for a total purchase price of $200,000 in two closings.”

FOXO TECHNOLOGIES INC. entered into Strata Purchase Agreement with ClearThink Capital Partners, LLC valued at $2,000,000 (effective 2023-10-13).

“On October 13, 2023, FOXO Technologies Inc. (the “Company”) entered into a Strata Purchase Agreement (the “Strata Purchase Agreement”) with ClearThink Capital Partners, LLC (“ClearThink”)”

FOXO TECHNOLOGIES INC. incurred loan of $42,500 with Andrew J. Poole at 13.25% per annum maturing one year from the issuance date.

“On October 2, 2023, FOXO Technologies Inc. (the “Company”) obtained a $42,500 loan from Andrew J. Poole, a director of the Company (the “Loan”), to be used to pay for the legal fees of Mitchell Silberberg & Knupp LLP through October 2023.”

Martin Ward was appointed as Interim Chief Financial Officer at FOXO TECHNOLOGIES INC..

“Martin Ward to serve as Interim Chief Financial Officer of the Company, effective as of Mr. Ward’s entry into his employment agreement with the Company”

Mark White was appointed as Interim Chief Executive Officer at FOXO TECHNOLOGIES INC..

“appointed Mark White to serve as Interim Chief Executive Officer of the Company, effective as of Mr. White’s entry into his employment agreement with the Company”